Diabetes itself affected working and wages more than control of blood sugar levels in a Mexican American population.
Electronic health record data can be used to predict patient absenteeism accurately. Predictive overbooking of missed appointments can significantly increase service utilization.
Diagnosis-related group coding determines eligibility for many Medicare bundled payment initiatives. This approach excluded many patients with chronic obstructive pulmonary disease likely to benefit while including others without the disease.
Institution of paperless credentialing is analyzed on a pre-/post-implementation basis to understand the impact on business and productivity.
Geisinger Health System’s $0 co-pay drug program for its chronically ill employee population is associated with positive cost savings and a 5-year return-on-investment of approximately 1.8.
This study evaluated economic outcomes of an insurer-led care management program for high-cost Medicaid patients using teams of community health care workers and nurses.
Real-time location systems can capture face time and trade-offs between face time and diagnostic testing so that clinicians' responses to time pressures can be measured.
This study describes the small number of individuals responsible for larger shares of healthcare cost persistently over a 3-year period.
It is important to take into account individual complexities such as comorbidities and pill burden when selecting antiretroviral therapy regimens for individuals living with HIV.
Substitutive Hospital at Home care for 4 common conditions is associated with cost savings.
The same simulation methodology used in the aviation industry was able to uncover latent environmental threats to patient safety.
Only 60% of hospitals display their cash prices and 5% display their minimum negotiated charges on their public websites; many hospitals are in violation of new federal legislation.
This study attempts to identify the sources of the significant 2.5-fold variation found in home health expenditures, a possible indicator of inefficiency and waste.
We surveyed biopharmaceutical manufacturers and payers to understand the prevalence and characteristics of value-based payment arrangements, as well as their implementation obstacles and success factors.
To improve formulary design processes and support payers in providing more effective healthcare, policy makers should consider involving commercial payers in the development of comparative effectiveness research and creation of research and treatment guidelines.